79175425 - D

Information

  • Trademark
  • 79175425
  • Serial Number
    79175425
  • Registration Number
    5293323
  • Filing Date
    December 29, 2014
    10 years ago
  • Registration Date
    September 26, 2017
    7 years ago
  • Transaction Date
    January 20, 2025
    19 days ago
  • Status Date
    April 12, 2024
    10 months ago
  • Published for Opposition Date
    November 08, 2016
    8 years ago
  • Location Date
    September 26, 2017
    7 years ago
  • Status Code
    709
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    THOMAS, JULIE
  • Attorney Docket Number
    36381-0018US
    Attorney Name
    Elizabeth Brenckman
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
3
Mark Identification
D
Case File Statements
  • GS0411: Entertainment television news programme services in the field of pharmaceutical products and sanitary preparations for medical purposes broadcast over the internet; organizing community festivals featuring primarily pharmaceutical exhibition for medical purposes; arranging professional workshop and training courses in the field of pharmaceutical products and medicine for medical purposes; training services in the field of pharmaceutical and sanitary preparations for medical purposes; education service, namely, providing tutoring in the field of pharmaceutical and sanitary preparations for medical purposes; providing information relating to organizing community cultural activities and contests
  • DM0000: The mark consists of a letter "D" within a hexagon.
  • GS0051: Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases also rare; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation also rare; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes also rare; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants
  • PM0001: DOMPE
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Conducting early evaluations in the field of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology, treatment of cancer, diabetes, analgesic preparations, nerve grow factors, oncology, organ transplantation, antibiotics, respiratory diseases, bone diseases, rare diseases; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, medical diagnostics, drug development and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer, diabetes, respiratory diseases, bone diseases, rare diseases, ocular disorders and diseases; research and development in the pharmaceutical and biotechnology fields
Case File Event Statements
  • 11/6/2015 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 12/18/2015 - 9 years ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/10/2015 - 9 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 11/12/2015 - 9 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/12/2015 - 9 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/12/2015 - 9 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/17/2015 - 9 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/25/2015 - 9 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/26/2015 - 9 years ago
    8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/1/2015 - 9 years ago
    9 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/1/2015 - 9 years ago
    10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/28/2016 - 8 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/28/2016 - 8 years ago
    12 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/1/2016 - 8 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/1/2016 - 8 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/2/2016 - 8 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/30/2016 - 8 years ago
    16 - FINAL REFUSAL WRITTEN Type: CNFR
  • 6/30/2016 - 8 years ago
    17 - FINAL REFUSAL E-MAILED Type: GNFR
  • 6/30/2016 - 8 years ago
    18 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 9/28/2016 - 8 years ago
    19 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 9/28/2016 - 8 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/5/2017 - 7 years ago
    31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/28/2016 - 8 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/19/2016 - 8 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/19/2016 - 8 years ago
    24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 10/19/2016 - 8 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/8/2016 - 8 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/8/2016 - 8 years ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/18/2016 - 8 years ago
    28 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 12/7/2016 - 8 years ago
    29 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 4/5/2017 - 7 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 12/26/2017 - 7 years ago
    41 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/9/2017 - 7 years ago
    32 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 5/9/2017 - 7 years ago
    33 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 5/10/2017 - 7 years ago
    34 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 5/12/2017 - 7 years ago
    35 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 6/3/2017 - 7 years ago
    36 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/21/2017 - 7 years ago
    38 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 8/21/2017 - 7 years ago
    37 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 8/21/2017 - 7 years ago
    39 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 9/26/2017 - 7 years ago
    40 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/12/2024 - 10 months ago
    48 - CANCELLED SECTION 71 Type: C71T
  • 12/13/2024 - a month ago
    49 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 12/29/2017 - 7 years ago
    42 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/29/2017 - 7 years ago
    43 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/26/2018 - 7 years ago
    44 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/12/2021 - 3 years ago
    45 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/4/2021 - 3 years ago
    46 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 9/26/2022 - 2 years ago
    47 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 1/19/2025 - 20 days ago
    50 - INVALIDATION PROCESSED Type: INPC
  • 1/19/2025 - 20 days ago
    51 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS